Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJ C SHAH

Allopathic & Osteopathic Physicians Family Medicine Geriatric Medicine

NPI
1053440503
CMS profile
92766
Location
CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$362.10

3 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $362.10 3

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
CVRx, Inc. $170.90 1
Bard Peripheral Vascular, Inc. $152.22 1
Boston Scientific Corporation $38.98 1

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJ C SHAH

NPI 1053440503 · CMS profile ID 92766

Allopathic & Osteopathic Physicians / Family Medicine / Geriatric Medicine

CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053440503?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJ C SHAH, NPI 1053440503, CMS profile ID 92766. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053440503?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RAJ C SHAH, NPI 1053440503, CMS profile ID 92766. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053440503?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RAJ C SHAH, NPI 1053440503, CMS profile ID 92766, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1053440503?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

3 matching records · $362.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 3 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–3 of 3.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Boston Scientific Corporation $38.9808/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021941923 CMS
Bard Peripheral Vascular, Inc. $152.2206/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023893923 CMS
CVRx, Inc. $170.9002/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058631215 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $67.68 2
PY2023 $362.10 3
PY2024 $286.48 2
PY2025 $1,019.05 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $5,701.20 5
PY2023 Principal investigator $166,342.96 20
PY2022 Principal investigator $454,172.73 48
PY2021 Principal investigator $501,964.34 72
PY2020 Principal investigator $499,828.82 52
PY2019 Principal investigator $212,426.78 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

52 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $186,835.00 12/22/2020 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants No dispute reported 06/30/2026 719479285
Principal investigator 1 Genentech, Inc. $11,721.51 12/14/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857140021
Principal investigator 1 Genentech, Inc. $8,764.00 12/09/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013575
Principal investigator 1 Janssen Research & Development, LLC $19,116.00 11/24/2020 Covered Recipient Teaching Hospital
Rush University Medical Center
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants No dispute reported 06/30/2026 719479279
Principal investigator 1 Genentech, Inc. $975.00 11/20/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013559
Principal investigator 1 Genentech, Inc. $5,150.97 11/13/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857140017
Principal investigator 1 Genentech, Inc. $3,191.00 10/23/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013545
Principal investigator 1 Genentech, Inc. $2,666.48 10/23/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857140013
Principal investigator 1 Genentech, Inc. $2,385.89 10/21/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857140007
Principal investigator 1 Genentech, Inc. $4,201.52 10/14/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857140001
Principal investigator 1 Genentech, Inc. $7,937.00 09/28/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013523
Principal investigator 1 Genentech, Inc. $12,479.71 09/16/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139997
Principal investigator 1 Genentech, Inc. $2,646.00 09/14/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857139993
Principal investigator 1 Genentech, Inc. $5,155.00 08/27/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013503
Principal investigator 1 Genentech, Inc. $7,874.00 08/27/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013509
Principal investigator 1 Genentech, Inc. $2,666.48 08/21/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139987
Principal investigator 1 Genentech, Inc. $3,138.54 08/17/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857139983
Principal investigator 1 Genentech, Inc. $1,950.00 07/29/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013487
Principal investigator 1 Genentech, Inc. $5,535.00 07/20/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013461
Principal investigator 1 Genentech, Inc. $1,267.00 07/20/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139973
Principal investigator 1 Genentech, Inc. $975.00 07/20/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139979
Principal investigator 1 Genentech, Inc. $10,304.00 07/01/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013443
Principal investigator 1 Genentech, Inc. $5,178.00 07/01/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013453
Principal investigator 1 Genentech, Inc. $1,333.24 06/25/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139969
Principal investigator 1 Genentech, Inc. $12,190.61 06/15/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139965
Principal investigator 1 Genentech, Inc. $6,198.16 06/12/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857139959
Principal investigator 1 Genentech, Inc. $975.00 05/25/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013437
Principal investigator 1 Genentech, Inc. $9,229.36 05/13/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857139953
Principal investigator 1 Genentech, Inc. $971.00 05/12/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139933
Principal investigator 1 Genentech, Inc. $975.00 05/12/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857139939
Principal investigator 1 Genentech, Inc. $1,411.00 05/12/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139943
Principal investigator 1 Genentech, Inc. $971.00 05/12/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857139949
Principal investigator 1 Genentech, Inc. $13,230.28 04/09/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857140027
Principal investigator 1 Genentech, Inc. $1,333.24 04/09/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857140031
Principal investigator 1 Genentech, Inc. $1,580.40 04/01/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857139929
Principal investigator 1 Genentech, Inc. $5,535.00 03/16/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013375
Principal investigator 1 Genentech, Inc. $3,621.60 03/10/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 743013301
Principal investigator 1 Genentech, Inc. $12,731.00 03/02/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 743013335
Principal investigator 1 Genentech, Inc. $20,497.00 02/27/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013359
Principal investigator 1 Genentech, Inc. $7,045.75 02/25/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 743013295
Principal investigator 1 Genentech, Inc. $2,571.38 02/14/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 743013287
Principal investigator 1 Genentech, Inc. $4,212.83 02/14/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 743013325
Principal investigator 1 Genentech, Inc. $34,262.00 02/13/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
GANTENERUMAB IN EARLY AD No dispute reported 06/30/2026 743013343
Principal investigator 1 Merck Sharp & Dohme Corporation $1,064.46 01/29/2020 Non-covered Recipient Entity
RUSH UNIVERSITY MEDICAL CENTER ALZHEIMERS DISEASE CENTER
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. No dispute reported 06/30/2026 740723221
Principal investigator 1 Merck Sharp & Dohme Corporation $17,396.96 01/24/2020 Non-covered Recipient Entity
RUSH UNIVERSITY MEDICAL CENTER ALZHEIMERS DISEASE CENTER
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. No dispute reported 06/30/2026 740723223
Principal investigator 1 Merck Sharp & Dohme Corporation $750.00 01/24/2020 Non-covered Recipient Entity
RUSH UNIVERSITY MEDICAL CENTER ALZHEIMERS DISEASE CENTER
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. No dispute reported 06/30/2026 740723263
Principal investigator 1 Merck Sharp & Dohme Corporation $756.28 01/24/2020 Non-covered Recipient Entity
RUSH UNIVERSITY MEDICAL CENTER ALZHEIMERS DISEASE CENTER
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. No dispute reported 06/30/2026 740723265
Principal investigator 1 Genentech, Inc. $3,593.22 01/16/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 743013319
Principal investigator 1 Genentech, Inc. $4,742.18 01/13/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 743013277
Principal investigator 1 Merck Sharp & Dohme Corporation $1,163.82 01/08/2020 Non-covered Recipient Entity
RUSH UNIVERSITY MEDICAL CENTER ALZHEIMERS DISEASE CENTER
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. No dispute reported 06/30/2026 740723267
Principal investigator 1 Genentech, Inc. $8,438.00 01/02/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 743013268
Principal investigator 1 Genentech, Inc. $8,935.95 01/02/2020 Covered Recipient Teaching Hospital
RUSH UNIVERSITY MEDICAL CENTER
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 743013311